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INTRODUCTION
Although the treatment and management of esophageal cancer
have evolved in recent years, with advances in diagnostic tech-
niques and the development of chemoradiotherapy, surgery re-
mains the cornerstone therapy of localized esophageal cancer (1-3).
However, the surgical procedure is associated with an extremely
high mortality rate as well as morbidity rate. Our previous study
showed, not only a remarkable improvement in the patients’ prog-
nosis after esophageal surgery but also a marked decrease in the
mortality and morbidity rates (4), whereas, a significant number of
severe postoperative complications developed and some of them
caused in-hospital death (5).
In patients with liver disease, there is high operative mortality
and morbidity after gastrointestinal and portal hypertension sur-
gery (6-8). Because of the etiologic relationship between alcohol
consumption and both liver dysfunction and esophageal cancer,
liver dysfunction occasionally is encountered in candidates for
esophageal cancer surgery (9). Due to the attendant risk of liver
dysfunction, extensive esophageal resections sometimes are con-
traindicated. In cases indicated for operation for esophageal cancer
coexisting liver dysfunction, a thorough preoperative evaluation
including the assessment of liver function is required along with
selection of an appropriate procedure and perioperative phase
management.
A two-stage operation was particularly applied for high-risk pa-
tients in the late 20th century (10, 11). Esophageal cancer usually
occurs in elderly patients who often have coexisting diseases, and
these co-morbidities can impair the tolerance of patients to the
invasiveness of esophageal surgery. Therefore, we have recently
readopted a two-stage operation for such high-risk patients (12).
In this study, we have evaluated our experience of 8 two-stage
operations performed for the patients with esophageal cancer con-
comitant with liver dysfunction. We herein show the usefulness of
this procedure for such high risk candidates.
PATIENTS AND METHODS
Patients
Two hundred sixty nine patients underwent esophagectomy
for esophageal cancer between April, 2005 and December, 2013,
at the Department of Surgery and Science, Kyushu University
Hospital in Japan. Among them, 8 patients with thoracic esopha-
geal squamous cell carcinoma underwent a two-stage operation
by reason of liver dysfunction. The surgical results after the two-
stage operation for those patients were analyzed in this study.
Indications of two-stage operation
The two-stage operation was indicated either mainly for the
“patient factor” when the patients’ general condition was not re-
tained to tolerate conventional esophagectomy and one-stage re-
construction, or for the “operation factor” when the operation itself
was complicated and invasive for patients or that an unexpected
event happened during esophagectomy (12). In a patient with
chronic liver disease, the degree of liver damage was evaluated
according to the Child-Pugh classification and the classification
presented by the Liver Cancer Study Group of Japan (13), which
consists of the factors such as the presence of controllable ascites,
a serum bilirubin level, a serum albumin level, an indocyanine
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green retention rate at 15 min, and a prothrombin activity. The
two-stage operation was applied when the patient fit at least two
categories among the presence of controllable ascites, a serum
bilirubin level of 2.0 -3.0 mg/dl, a serum albumin level of 3.0 -3.5
g/dl, an indocyanine green retention rate of 15-40% at 15 min, and
a prothrombin activity of 50-80% and/or a typical liver cirrhosis
pattern (irregular or nodular surface and/or dull edge of the liver)
was presented by CT scan. Other criteria were described in the
previous paper (12).
Table 1 summarizes the patients’ backgrounds. The average age
of the patients was 65.3 years old (range : 59-74 years old). All pa-
tients were male. The underlying liver disease was alcoholic liver
damage in 7 patients and hepatitis type C in 1 patient. One patient
was categorized into Child-Pugh B, while other 7 patients into
Child-Pugh A. Three patients were categorized into liver damage
grade B by classification of the Liver Cancer Study Group of Japan,
while other 4 patients into grade A. The average of the indocyanine
green retention rate at 15 min was 20.9% (range : 7.2 -33.5%). The
preoperative chemoradiotherapy was performed for 3 patients in-
cluding definitive chemoradiotherapy for 1 patient. For case #7, the
definitive chemoradiotherapy (total of 70 Gy) was indicated for the
synchronous hypopharyngeal cancer, on the other hand the preop-
erative chemoradiotherapy (total of 41.4 Gy) was simultaneously
performed for the cStage I esophageal cancer in order to avoid
disease progression while definitive chemoradiotherapy for the
hypopharyngeal cancer.
Methods of two-stage operation
The 1st stage operation consists of a resection of the thoracic
esophagus, cervical esophagostomy and tube jejunostomies. A right
thoracotomy was followed by esophagectomy as well as mediasti-
nal lymphadenectomy. The distal part of the esophagus was dis-
sected and cut with a linear stapler at the level of the esophago-
cardial junction. The upper thoracic esophagus was also cut with
the stapler. A tube for nutrition is inserted into distal part of jeju-
num after minimal laparotomy, while another tube is also inserted
into the proximal jejunum to avoid excessive pressure in the distal
margin of the esophagus. We prefer jejunostomy to gastrostomy
for nutrition, because gastrostomy may be disadvantageous for re-
construction with gastric tube. We usually start the enteral nutri-
tion on the 3rd postoperative day after the 1st stage operation. The
cervical esophagostomy was made. Cervical lymphadenectomy was
performed at the 1st stage operation if indicated. The timing of the
2nd operation is based on the time when the performance status
recovered to the same level as that before the 1st stage operation.
Laparotomy was followed by abdominal lymph node dissection. A
narrow gastric tube, 3.5 cm in width was made (14). The gastric
tube was pulled via either the subcutaneous or retrosternal route
to the neck. Cervical anastomosis was performed with either hand
sutures or the triangular stapling method (15). The splenectomy
was performed for 3 patients ; for the purpose of portal decom-
pressing effect for case #1 (16), and to control bleeding the splenic
hilum for case #5 and #6.
Post-operative complications
Surgical complications, such as anastomotic leakage, pyothorax
or chylothorax, and wound infection which required for drainage
were evaluated. Regarding medical complications, not only pulmo-
nary complications such as pneumonia and hypoxia requiring re-
intubation, but also cardiac complications, such as severe arrhyth-
mia, myocardial infarction, and pulmonary embolism were examined.
Staging of the tumor
The clinicopathological factors were evaluated according to the
guidelines for clinical and pathologic studies on carcinoma of the
esophagus (17). The staging of the tumor was based on the TNM
classification defined by UICC (18) and depth of invasion and
lymph node metastasis were defined by clinical findings.
RESULTS
Surgical results
Table 2 shows the surgical results and postoperative complica-
tions. The average time of the 1st stage operation was 410.0 min
(range, 204-625 min), while that of the 2nd stage operation was
438.9 min (range ; 362-557 min). The average amount of blood loss
in the 1st stage operation was 433.5 ml (range, 125-720 ml), while
that in the 2nd stage operation was 1556.8 ml (range ; 319-5086 ml).
The average duration between 1st stage operation and the 2nd stage
operation was 29.8 days (range, 10-90 days). The gastric tube was
used as the reconstructed organ for all patients. The antesternal
route was selected for 5 patients (62.5%) and the retrosternal route
was for 3 patients (37.5%).
Postoperative complications
After the 1st stage operation, no postoperative complications were
observed. On the other hand, postoperative complications devel-
oped in 5 (62.5%) patients after the 2nd stage operation. Anastomotic
leakage developed in 4 patients (50.0%) and it was successfully
treated by a repair operation with the major pectoral muscle in two
patients (19). Left pleural effusion occurred in 1 patient. The trans-
verse colon perforation occurred after 2nd stage operation and
the temporal ileostomy was made on 15th postoperative day in
case #8. In the 2nd stage operation of case #8, the adhesion was
observed in the peritoneal cavity. We suggested that the late phase
Table 1. Clinical backgrounds
Case # Age Sex Location cStage Type Child -Pugh Liver damage* ICGR15 Preoperative therapy
1 61 Male Mt cT1b N0 M0 Stage I Alcoholic B B 33.5 dCRT
2 74 Male Mt cT3 N0 M0 Stage IIA Alcoholic A B 27.4 none
3 59 Male Mt cT3 N1 M0 Stage III HCV A A 17.9 none
4 65 Male Mt cT3 N1 M0 Stage III Alcoholic A A 18.0 NACRT
5 68 Male Lt cT1a N0 M0 Stage I Alcoholic A A 7.2 none
6 64 Male Mt cT1b N0 M0 Stage I Alcoholic A B 29.4 none
7 67 Male Lt cT1b N0 M0 Stage I Alcoholic A A 12.9 NACRT
8 64 Male Lt cT1b N0 M0 Stage I Alcoholic A A 15.0 none
HCV : hepatitis type C ; dCRT : definitive chemoradiotherapy ; NACRT : neoadjuvant chemoradiotherapy
*The classification presented by the Liver Cancer Study Group of Japan.
M. Yasuda, et al. Esophageal cancer with liver disease150
colon perforation occurred due to injury of marginal artery of trans-
vers colon resulted from adhesiolysis during the 2nd stage opera-
tion. Pneumonia was not observed through 1st and 2nd stage op-
eration. We evaluated the degree of ascites and the increase of
aspartate aminotransferase (AST) and alanine aminotransferase
(ALT) after the 1st and 2nd stage operation, using Common Termi-
nology Criteria for Adverse Events (CTCAE) ver.4.0 grading scale.
As a result, no major complications (CTCAE grade3) were ob-
served both after the 1st and 2nd stage operation. No in-hospital
death was experienced in this series.
Figure 1 shows the images of representative case (case #5). The
patient was 68 year-old male. He had a history of heavy alcohol
drinking and smoking. The endoscopy examination revealed the
multiple Lugol -voiding lesions on middle and lower thoracic esopha-
gus. The pathological examination from biopsy specimen revealed
moderately squamous cell carcinoma. His liver function was evalu-
ated as Child-Pugh A and grade A by the classification of the Liver
Cancer Study Group of Japan. However, the findings from CT scan
indicated typical liver cirrhosis pattern. He underwent a two-stage
operation and had uneventful clinical course.
DISCUSSION
The patients with esophageal cancer are often accompanied with
chronic hepatitis or cirrhosis, since alcohol abuse could be a com-
mon etiological risk of both diseases. Although the major cause
of chronic liver disease in Japanese patients is viral infection, most
of the patients in this study were alcoholics. This may be attribut-
able to the carcinogenic property of alcohol in esophageal squamous
cell carcinoma, which is the dominant histological type of esopha-
geal cancer in Japan (20-23). In general, there are the various post-
operative complications likely occurred in the patients with liver
dysfunction : impairment of hepatic function, increased ascites,
increased susceptibility to infection and hemorrhagic tendency.
Besides these, anastomotic leakage occurs as frequently as 13% to
83% in operations involving reconstruction of the gastrointestinal
tract and has been reported to be associated with a fatal outcome
if accompanied by pyothorax and sepsis (9). It has indicated that
depressed hemoglobin oxygen saturation consequent to reduced
arterial blood inflow, increased shunt blood flow caused by conges-
tion of the reconstructed gastric tube and delay of wound healing
possibly account for the high incidence of anastomotic leakage in
those patients (24). Therefore, special attentions are required when
we establish the treatment strategy for those patients.
In previous study, Fekete et al. (9) reported the treatment re-
sults of esophagogastrectomy for carcinoma of the esophagus or
cardia performed for 23 patients with liver cirrhosis. They dem-
onstrated that 6 patients (26%) died after operation and the only
significant preoperative predictor of mortality was a prothrombin
time less than or equal to 60% of normal. Tachibana et al. (25) re-
ported that 3 (16.7%) out of 18 patents with esophageal cancer con-
comitant with liver cirrhosis died of postoperative complications.
They also showed that patients who had both weight loss and hy-
poalbuminemia had a significantly higher mortality rate than those
who did not. In the current study, no in-hospital death due to post-
operative complications occurred in any patients, which suggests
the safety of two-stage operation for the patients with esophageal
cancer concomitant with liver dysfunction.
The mortality rates from leakage and from sepsis in cirrhotic
patients were reported to be 50-66% and 60-67%, respectively (9,
25). One possible reason for the high mortality rate due to septic
complications is that cirrhotic patients are under severe immuno-
suppressive conditions to tolerate infectious attack (26). Anasto-
motic leakage developed in 4 patients in this study. However, we
have never experienced the fetal complications following anasto-
motic leakage. Pulmonary infection also is a well -known cause of
in-hospital death after esophageal surgery (4, 27). We previously
reported that postoperative pneumonia might be associated with
subsequent anastomotic insufficiency (28). In this study, pneumonia
was not observed both after 1st and 2nd stage operation. Especially
for patients associated with severe liver dysfunction, the surgical
stress of esophagectomy followed by reconstruction might be too
excessive to overcome. The liver dysfunction can result in increas-
ing blood loss especially in the 2nd stage operation due to portal
hypertension. In fact, the amount of blood loss (including ascites)
Figure 1. The CT findings of representative case who underwent the
two-stage operation.
Table 2. Surgical results and postoperative complications
Case # 1st, OT (min) 1st, BL (ml) 1st, complications Interval (days) Reconstruction 2nd, OT (min) 2nd, BL (ml) 2nd, complications
1 204 125 none 90 gastric tube/AS 362 2068 none
2 625 691 none 21 gastric tube/AS 486 1420 leak
3 354 400 none 10 gastric tube/RS 407 518 none
4 566 720 none 21 gastric tube/AS 404 855 leak
5 420 624 none 27 gastric tube/AS 436 1610 none
6 356 400 none 18 gastric tube/AS 557 5086 leak, pleural effusion
7 347 250 none 28 gastric tube/RS 376 578 leak
8 408 258 none 23 gastric tube/RS 483 319 colon perforation
OT : operation time ; BL : blood loss ; AS : antesternal ; RS : retrosternal
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in the 2nd stage operation was larger than that in the 1st stage op-
eration in this study. When the gastric tube was made, the right
(No. 1) and left (No. 2) cardiac, along the lesser curvature (No. 3),
and along the left gastric artery (No. 7) lymph nodes were usually
dissected. However, we think that abdominal lymph nodes dissec-
tion could be minimized to avoid large amount of blood loss for the
patients with portal hypertension.
Regarding therapeutic strategy for high-risk patients, it seems
to be a reasonable idea that definitive chemoradiotherapy should
be initially indicated since it may be effective and less invasive. In
patients with liver cirrhosis, nevertheless, it is common that pan-
cytopenia and esophageal varices due to hypersplenism are present
even prior to treatment of the cancer. Eventually, worsening of
these complications occurs owing to adverse events associated with
radiation therapy combined with chemotherapy such as myelosup-
pression, esophagitis and liver dysfunction, and hence to failure in
accomplishing the treatment. There is also a risk of rupture of
esophageal varices. Furthermore, salvage esophagectomy for either
remnant or recurrent disease would be difficult in such extremely
high-risk patients due to the severe general risk and long term
toxicity (29-32). As a result, such patients would lose the chance
for the cure of the disease. Therefore, we have principally indicated
two-stage operation for high risk patients who fulfill the criteria of
organ function (12), while carefully taking account on the patients’
general status and social background as well as the overall pre-
dicted surgical stress.
The prolonged hospital stay is a disadvantage of two-stage op-
eration. It may not only induce mental stress and be an economic
burden to the patient, but also results in the delay of treatment if
the patient has either abdominal lymph node metastasis. When a
staged operation is indicated, special attention should be paid to
such possible disadvantages. The duration between the 1st and 2nd
stage operation varies between the patients. Early and adequate
recovery from surgical stress of the esophagectomy is warranted ;
however, high-risk patients often took a long time to recover. Full
recovery of nutrition as well as performance status is essential for
the 2nd stage operation. Early enteral feeding is superior to par-
enteral nutrition for the recovery after esophagectomy (33). We,
therefore, establish tube jejunostomy and adopt enteral nutrition
as soon as possible after the 1st stage operation.
We have readopted the two-stage operation, with the goal of
achieving increased resectability as well as in order to perform a
safer operation in high risk patients. We believe that a two-stage
operation would be less invasive surgery and it should be aggres-
sively performed for the patients with esophageal cancer concomi-
tant with liver dysfunction. Further investigations concerning two-
stage operation for such poor risk patients are required.
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